Company / Total Assets
C4 Therapeutics, Inc. Total Assets History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Total Assets
$359.1M
FY2025
5-year range
$349.6M / $430.8M
FY2022-FY2025
Trend
+2.7%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Total Assets returned to growth in FY2025 after 2 years of decline, reaching $359M.
Based on SEC 10-K filings.
$359M in FY2025 with a 3-year CAGR of -5.9%.
Declined from $376M to $359M over the past 2 years.
Total Assets over time
Growth rates
- 3-Year CAGR
- -5.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -5.9%, indicating a declining trend.
- In FY2025, total assets increased 2.7% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.14 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Total AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $359.1M | +2.7% |
| FY2024 | $349.6M | -7.1% |
| FY2023 | $376.5M | -12.6% |
| FY2022 | $430.8M | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026